Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Thomssen

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Der Gynakologe|May 2, 2022
[Management of immune-related adverse events (irAEs) - what needs to be respected?]Christoph Thomssen
Breast Care (Basel, Switzerland)|September 9, 2010
Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual PatientChristoph Thomssen
Breast Care (Basel, Switzerland)|July 23, 2011
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast CancerChristoph Thomssen, Nadia Harbeck
Breast Cancer Research and Treatment|January 8, 2008
Decline in breast cancer incidence in the United States: what about male breast cancer?Andreas Stang, Christoph Thomssen
Acta Histochemica|September 12, 2006
Changes in the extracellular matrix in periurethral tissue of women with stress urinary incontinenceChristian Goepel, Christoph Thomssen
Breast Care (Basel, Switzerland)|May 8, 2014
Cutting-edge therapy concepts - cure metastatic breast cancer?Christoph Thomssen, Nadia Harbeck
Breast Care (Basel, Switzerland)|November 7, 2018
Adjuvant Therapy of Breast Cancer: Can We Do Better?Christoph Thomssen, Wolfgang Janni
The Oncologist|February 1, 2011
A new look at node-negative breast cancerNadia Harbeck, Christoph Thomssen
Breast Care (Basel, Switzerland)|February 20, 2014
ABC2 Consensus Conference on Advanced Breast Cancer: Brief Summary of the Consensus Panel on Saturday November 9, 2013Christoph Thomssen, Nadia Harbeck
Thrombosis and Haemostasis|March 30, 2007
Hormonal therapy with patch or pill: how much does it matter?Katrin Schaudig, Christoph Thomssen
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Der Gynakologe|May 2, 2022
[Management of immune-related adverse events (irAEs) - what needs to be respected?]Christoph Thomssen
Breast Care (Basel, Switzerland)|September 9, 2010
Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual PatientChristoph Thomssen
Breast Care (Basel, Switzerland)|July 23, 2011
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast CancerChristoph Thomssen, Nadia Harbeck
Breast Cancer Research and Treatment|January 8, 2008
Decline in breast cancer incidence in the United States: what about male breast cancer?Andreas Stang, Christoph Thomssen
Acta Histochemica|September 12, 2006
Changes in the extracellular matrix in periurethral tissue of women with stress urinary incontinenceChristian Goepel, Christoph Thomssen
Breast Care (Basel, Switzerland)|May 8, 2014
Cutting-edge therapy concepts - cure metastatic breast cancer?Christoph Thomssen, Nadia Harbeck
Breast Care (Basel, Switzerland)|November 7, 2018
Adjuvant Therapy of Breast Cancer: Can We Do Better?Christoph Thomssen, Wolfgang Janni
The Oncologist|February 1, 2011
A new look at node-negative breast cancerNadia Harbeck, Christoph Thomssen
Breast Care (Basel, Switzerland)|February 20, 2014
ABC2 Consensus Conference on Advanced Breast Cancer: Brief Summary of the Consensus Panel on Saturday November 9, 2013Christoph Thomssen, Nadia Harbeck
Thrombosis and Haemostasis|March 30, 2007
Hormonal therapy with patch or pill: how much does it matter?Katrin Schaudig, Christoph Thomssen
Pageof 23